
Combining the chemotherapy streptozotocin with various mTOR inhibitors was found to effectively target tumors in preclinical studies for pancreatic neuroendocrine tumors (pNETs).

Combining the chemotherapy streptozotocin with various mTOR inhibitors was found to effectively target tumors in preclinical studies for pancreatic neuroendocrine tumors (pNETs).

Treatment with capecitabine and temozolomide is an effective therapy for patients with metastatic pancreatic neuroendocrine tumors.


October 16th 2015

October 16th 2015